BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25928658)

  • 21. No foot-and-mouth disease virus transmission between individually housed calves.
    Bouma A; Dekker A; de Jong MC
    Vet Microbiol; 2004 Jan; 98(1):29-36. PubMed ID: 14738779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contact Challenge of Cattle with Foot-and-Mouth Disease Virus Validates the Role of the Nasopharyngeal Epithelium as the Site of Primary and Persistent Infection.
    Stenfeldt C; Hartwig EJ; Smoliga GR; Palinski R; Silva EB; Bertram MR; Fish IH; Pauszek SJ; Arzt J
    mSphere; 2018 Dec; 3(6):. PubMed ID: 30541776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of seroreagents to FMDV in the cattle population in Poland: results of 9-year monitoring studies.
    Niedbalski W
    Pol J Vet Sci; 2003; 6(1):1-5. PubMed ID: 12675463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Within herd transmission and evaluation of the performance of clinical and serological diagnosis of foot-and-mouth disease in partially immune cattle herds.
    Gonzales JL; Barrientos MA; Quiroga JL; Ardaya D; Daza O; Martinez C; Orozco C; Crowther J; Paton DJ
    Vaccine; 2014 Oct; 32(47):6193-8. PubMed ID: 25261377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NSP immune response of vaccinated animals after in-field exposure to FMDV.
    Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M
    Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus.
    Eblé PL; Bouma A; de Bruin MG; van Hemert-Kluitenberg F; van Oirschot JT; Dekker A
    Vaccine; 2004 Mar; 22(11-12):1372-8. PubMed ID: 15063559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission characteristics and optimal diagnostic samples to detect an FMDV infection in vaccinated and non-vaccinated sheep.
    Eblé PL; Orsel K; van Hemert-Kluitenberg F; Dekker A
    Vet Microbiol; 2015 May; 177(1-2):69-77. PubMed ID: 25790732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.
    Lee F; Jong MH; Yang DW
    Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of factors associated with increased excretion of foot-and-mouth disease virus.
    Bravo de Rueda C; Dekker A; Eblé PL; de Jong MC
    Prev Vet Med; 2014 Jan; 113(1):23-33. PubMed ID: 24182985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of subclinical foot-and-mouth disease virus infection in young calves born from clinically recovered cow under natural condition.
    Ranjan R; Biswal JK; Subramaniam S; Dash BB; Singh KP; Arzt J; Rodriguez LL; Pattnaik B
    Trop Anim Health Prod; 2018 Jun; 50(5):1167-1170. PubMed ID: 29388163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
    Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foot-and-mouth disease in North American bison (Bison bison) and elk (Cervus elaphus nelsoni): susceptibility, intra- and interspecies transmission, clinical signs, and lesions.
    Rhyan J; Deng M; Wang H; Ward G; Gidlewski T; McCollum M; Metwally S; McKenna T; Wainwright S; Ramirez A; Mebus C; Salman M
    J Wildl Dis; 2008 Apr; 44(2):269-79. PubMed ID: 18436660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion in experimentally infected cattle.
    Fowler V; Bashiruddin JB; Belsham GJ; Stenfeldt C; Bøtner A; Knowles NJ; Bankowski B; Parida S; Barnett P
    Vet Microbiol; 2014 Feb; 169(1-2):58-66. PubMed ID: 24438986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
    Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic immune response and virus persistence after foot-and-mouth disease virus infection of naïve cattle and cattle vaccinated with a homologous adenovirus-vectored vaccine.
    Eschbaumer M; Stenfeldt C; Rekant SI; Pacheco JM; Hartwig EJ; Smoliga GR; Kenney MA; Golde WT; Rodriguez LL; Arzt J
    BMC Vet Res; 2016 Sep; 12():205. PubMed ID: 27634113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus.
    Jaworski JP; Compaired D; Trotta M; Perez M; Trono K; Fondevila N
    J Virol Methods; 2011 Dec; 178(1-2):191-200. PubMed ID: 21946290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.